Our study provides evidence that miR-146a is induced by the same MAPK/AKT pathway that sustains melanoma growth at the earliest stages of transformation, when it could exert an anti-melanoma function by repressing Jmjd6 and perhaps also pro-tumoral inflammation. This evidence concerns the gene AKT1 and melanoma.